Curis competitors

Curis Competitors include Ourotech, Cleveland BioLabs, Heat Biologics and Immune Design.
Add company...
Curis
Curis
Curis is a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers.
Ourotech
Ourotech
Ourotech is changing the way cancer drugs are tested for the most innovative treatments.
Cleveland BioLabs
Cleveland BioLabs
CBLI’s mission is to develop and commercialize innovative drugs to treat cancer and protect healthy tissues from radiation, chemotherapy or ischemic conditions.
Heat Biologics
Heat Biologics
Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.
Immune Design
Immune Design
Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.
Founding Date
Founding Date
2000
Founding Date
2015
Founding Date
2003
Founding Date
2008
Founding Date
2008
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Lexington, US HQ
Locations
Waterloo, CA HQ
Locations
Buffalo, US HQ
Locations
Durham, US HQ
Locations
Seattle, US HQ
South San Francisco, US
Employees
Employees
555% decrease
Employees
325% decrease
Employees
1220% decrease
Employees
19
Employees
5510% increase
Valuation ($)
Valuation ($)
27.8 m
Valuation ($)
N/A
Valuation ($)
20.1 m
Valuation ($)
41.9 m
Valuation ($)
75.6 m
Twitter followers
Twitter followers
52
Twitter followers
272
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$9.9m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$7.2m (FY, 2017)
Net income
Net income
($53.3m) (FY, 2017)
Net income
N/A
Net income
($9.8m) (FY, 2017)
Net income
($12.4m) (FY, 2017)
Net income
($51.9m) (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Ourotech
HQ
Waterloo, CA
Employees
3↓ 25% decrease

Ourotech is changing the way cancer drugs are tested for the most innovative treatments.

View company
Cleveland BioLabs
HQ
Buffalo, US
Employees
12↓ 20% decrease

CBLI’s mission is to develop and commercialize innovative drugs to treat cancer and protect healthy tissues from radiation, chemotherapy or ischemic conditions.

View company
Heat Biologics
HQ
Durham, US
Employees
19

Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.

View company
Immune Design
HQ
Seattle, US
Employees
55↑ 10% increase

Immune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.

View company